Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangitis × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3 Head and Neck Neoplasms 2 Depression 2 Breast Neoplasms 2 Stomatitis 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Lung Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Cancer Pain 1 Anxiety Disorders 1 Agnosia 1

Interventions

Midazolam 1 Meperidine 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed

Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡